Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
暂无分享,去创建一个
Martijn H Breuning | Christopher J Ward | Dorien J M Peters | M. DeRuiter | M. Breuning | D. Peters | I. L. Lantinga-van Leeuwen | J. Dauwerse | H. Baelde | W. Leonhard | A. van de Wal | C. Ward | S. Verbeek | Emile de Heer | Marco C Deruiter | Emile de Heer | Sjef Verbeek | Irma S Lantinga-van Leeuwen | Johannes G Dauwerse | Hans J Baelde | Wouter N Leonhard | Annemieke van de Wal
[1] H. Cantiello,et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel , 2001 .
[2] A. Pierides,et al. Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease. , 2000, Human molecular genetics.
[3] Lin Geng,et al. Cardiac defects and renal failure in mice with targeted mutations in Pkd2 , 2000, Nature Genetics.
[4] V. Sukhatme,et al. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Kucherlapati,et al. Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease , 1998, Cell.
[6] M. Lewandoski. Conditional control of gene expression in the mouse , 2001, Nature Reviews Genetics.
[7] R. Fodde,et al. CANCER BIOLOGY: Enhanced: A Matter of Dosage , 2002 .
[8] K. Brindle,et al. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. S. St George-Hyslop,et al. Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. , 1999, Journal of the American Society of Nephrology : JASN.
[10] E. Coto,et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2 , 1999, The Lancet.
[11] 元史 服部,et al. 海外文献紹介 : Expression of Podocyte-Associated Molecules in Acquired Human Kidney Diseases , 2004 .
[12] H. Cantiello,et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Reeders. Multilocus polycystic disease , 1992, Nature Genetics.
[14] K. Klinger,et al. Polycystin 1 is required for the structural integrity of blood vessels. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] R. Perrone. Extrarenal manifestations of ADPKD. , 1997, Kidney international.
[16] P. George-Hyslop,et al. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations , 2000, Nature Genetics.
[17] P. Harris,et al. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. , 1999, Kidney international.
[18] John M. Maris,et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.
[19] L. Sandkuijl,et al. Genetic heterogeneity of polycystic kidney disease in Europe. , 1992, Contributions to nephrology.
[20] Weining Lu,et al. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation , 1997, Nature Genetics.
[21] S. Somlo,et al. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. , 2003, Human molecular genetics.
[22] Siep Thomas,et al. THE POLYCYSTIC KIDNEY-DISEASE-1 GENE ENCODES A 14-KB TRANSCRIPT AND LIES WITHIN A DUPLICATED REGION ON CHROMOSOME-16 , 1994 .
[23] X. Estivill,et al. Abdominal aortic aneurysms and autosomal dominant polycystic kidney disease. , 1996, Journal of the American Society of Nephrology : JASN.
[24] P. Verroust,et al. The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology. , 2002, Kidney international.
[25] E. Avner,et al. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. , 2003, Kidney international.
[26] J. Hughes,et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome , 1994, Nature Genetics.
[27] M. Breuning,et al. Autosomal dominant polycystic kidney disease: modification of disease progression , 2001, The Lancet.
[28] F. Alt,et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Trudel,et al. Distinct and common developmental expression patterns of the murine Pkd2 and Pkd1 genes , 2000, Mechanisms of Development.
[31] L. Guay-Woodford. Murine models of polycystic kidney disease: molecular and therapeutic insights. , 2003, American journal of physiology. Renal physiology.
[32] G. Germino,et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents , 2000, Nature.
[33] The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16 , 2004, Pediatric Nephrology.
[34] Vincent H Gattone,et al. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist , 2003, Nature Medicine.
[35] Hongyu Zhao,et al. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease. , 2002, Human molecular genetics.
[36] P. Ratcliffe,et al. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Sharpe,et al. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. , 2000, Human molecular genetics.
[38] G. Germino,et al. The Molecular Basis of Focal Cyst Formation in Human Autosomal Dominant Polycystic Kidney Disease Type I , 1996, Cell.
[39] P. Wilson,et al. Polycystic kidney disease. , 2004, The New England journal of medicine.
[40] D. Chauveau,et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. , 1994, Kidney international.
[41] N. Tamaki,et al. Polycystic kidney disease and intracranial aneurysms. Early angiographic diagnosis and early operation for the unruptured aneurysm. , 1983, Journal of neurosurgery.
[42] S. Somlo,et al. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease , 2004, Nature Medicine.
[43] S. Tapscott,et al. Modeling stochastic gene expression: implications for haploinsufficiency. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[44] P. Gabow,et al. Autosomal dominant polycystic kidney disease--more than a renal disease. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] D. Wiebers,et al. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. , 1993, Journal of the American Society of Nephrology : JASN.